Order

Size
Price
Stock
Qty

SP 600125

 - NSC 75890
Axon 2519
Based on 337 publications in PubMed
CAS:  129-56-6
Purity:  98%
  • Soluble in DMSO
  • MF:  C14H8N2O
  • MW:  220.23

Description

Reversible ATP-competitive JNK inhibitor (IC50 values 40 nM, 40 nM, and 90 nM for JNK1, JNK2 and JNK3, respectively) with >20-fold selectivity vs. a range of kinases and enzymes tested. SP600125 caused G2/M cell cycle arrest and elevation of cyclin B1 and p27(kip), thereby inhibiting cell proliferation and increasing apoptosis in multiple cell lines. Moreover, SP600125 dose dependently inhibits phosphorylation of c-Jun, the expression of inflammatory genes COX-2, IL-2, IFN-γ, TNF-α, and prevents activation and differentiation of primary human CD4 cell cultures; SP600125 has proven to be a useful tool for isolation, generation, derivatization and stabilization of naive human pluripotent stem cells in so called NHSM conditions developed at the Weizmann Institute of Science.

*Promotion: SP 600125 is also part of Inhibitor Set(s):

Naive Stem Cell NHSM inhibitor Set (Axon 5010)

Related Products

AXON ID NAME FROM PRICE
1291 AEG 3482

From €90.00

2002 Bentamapimod

From €70.00

2025 CC-401

From €120.00

2361 JNK-IN-8

From €95.00

2365 SR 3576

From €135.00

2634 CC-930

From €95.00

2949 JNK inhibitor VIII

From €105.00

3625 GNE-3511

From €90.00

5010 Naive Stem Cell NHSM inhibitor Set

From €230.00

Loading...